Correlation of Leptin and Vaspin Serum Concentration in Newly Diagnosed Type 2 Diabetes Mellitus

Main Article Content

K. Priya
S. K. Bansal
D. K. Sharma
K. Y. Birendra

Abstract

Objectives: The aim of the study was to explore the correlation of circulating leptin and vaspin levels with lipid profile, fasting blood sugar, HbA1c and anthropometric variable as inflammatory markers between diabetic patients and non-diabetic subjects.

Material and Methods: This study was conducted with 120 newly diagnosed type 2 diabetes mellitus (T2DM) patients with age-matched 120 non-diabetic subjects as controls.

Results: We found that there is significant increase in the parameters like serum Leptin, Vaspin, FBS, PPBS, HbA1c and lipid profile (TC, TG & VLDL). No significant differences were found between BMI, LDL & HDL parameters of T2DM patients compared to non-diabetic subjects. The results have been shown a significant positive correlation between Vaspin and Leptin in T2DM patients, (r = .755) and (P˂0.01) as compared to controls. The body mass index was positively correlated with Vaspin in T2DM patients, (r = .50) and (P <0.01) and with leptin in T2DM patients, (r = .265) and (P <0.01). A positive correlation had also observed between vaspin and LDL in T2DM patients, (r = .189) and (p <0.05). We also found that significant increased level of leptin and vaspin in females compared to males in our study group.

Conclusions: Serum leptin and vaspin level is positively associated with BMI and LDL and negatively correlated with fasting blood sugar, post-prandial glucose, HbA1c, VLDL and age.

Keywords:
T2DM, leptin, vaspin and BMI.

Article Details

How to Cite
Priya, K., K. Bansal, S., K. Sharma, D., & Y. Birendra, K. (2020). Correlation of Leptin and Vaspin Serum Concentration in Newly Diagnosed Type 2 Diabetes Mellitus. International Journal of Biochemistry Research & Review, 29(1), 1-9. https://doi.org/10.9734/ijbcrr/2020/v29i130160
Section
Original Research Article

References

Kershaw EE, Flier JS, et al. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548-56.

Bakker W, Eringa EC, et al. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res. 2009; 335:165-89.

Kowalska et al. Role of adipose tissue in the development of vascular complications in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2007;78:14-22.

Yanagawa T, Taniguchi, et al. Leptin, triglycerides and interleukin 6 are independently associated with C-reactive protein in Japanese type 2 diabetic patients. Diabetes Res Clin Pract. 2007; 75:2-6.

Ley SH, Harris et al. Adipokines and incident type 2 diabetes in an aboriginal Canadian [corrected] population: The Sandy Lake health and diabetes project. Diabetes Care. 2008;31:1410–5.

Schmidt MI, Duncan et al: Leptin and incident type2 diabetes: Risk or Protection. Diabetologia. 2006;49:2086–96.

Hida K, Wada J, Eguchi J, Zhang H, Baba M, et al. Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA. 2005;102:10610–5.

Kloting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, et al. Vaspin gene expression in human adipose tissue: Association with obesity and type 2 diabetes. Biochem Biophys Res Commun. 2006;339:430–6.

Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes. 2008; 57:1501–7.

Aktas B, Yilmaz Y, Eren F, Yonal O, Kurt R, et al. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. Metabolism. 2011; 60:544–9.

Aust G, Richter O, Rohm S, Kerner C, Hauss J, et al. Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis. 2009;204:262–8.

Abdelgadir M, Elbagir M, et al. Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan. Metabolism. 2002;51:304–6.

Bahceci M, et al. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high-sensitivity C - reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest. 2007;30:210–4.

Alberti KG and Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine. 1998; 15(7):539-53.

Ahmed A E, Mohamed A M, et al. Correlation between plasma leptin hormone in diabetic patients and the extent of coronary artery disease. Menoufia Medical Journal. 2018;31:607–12.

Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor.Annals of clinical Biochemistry.1969;6(1):24-7.

Sacks DB. Carbohydrates; determination of glucose in body fluids: Tietz textbook of clinical chemistry and molecular diagnostics, 5th ed. Elsevier, USA. 2012; 718-21.

Allain CC, Poon LS, Chan CS, Richmond WF, Fu PC. Enzymatic determination of total serum cholesterol. Clinical Chemistry.1974;20(4):470-5.

National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation. 2002;106:3143-421.

Remaley AT, Rifai N, Warnick GR. Lipids, Lipoproteins, Apolipoproteins and Other cardiovascular risk factors: Tietz textbook of clinical chemistry and molecular diagnostics, 5th Edit. Elsevier, USA. 2012; 776.

Castelli WP, et al. HDL cholesterol and other lipids in coronary heart disease. Circulation. 1977;55:767.

Williams P, et al. High density lipoprotein and coronary risk factor. Lancet. 1979; 1:72.

Kannel WB, Castelli WP, et al. Cholesterol in the prediction of atherosclerotic disease; new perspectives based on the Framingham study. Ann. Intern. Med. 1979;90:85.

Badimon JJ, Badimon L, Fuester V, et al. Regression of atherosclerotic lesions by high-density lipoprotein plasma fraction in the cholesterol-fed rabbit. Journal of Clinical Investigation. 1990;85(6):1234-41.

Gordon T, et al. High density lipoprotein as a protective factor against coronary heart disease. Am .J. Med. 1977;62:707.

Crouse JR, et al. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res. 1985;26:566.

Trivelli LA, Ranney HM, et al. Hemoglobin components in patients with diabetes mellitus. New England Journal of Medicine.1971;284(7):353-7.

Nathan DM, Singer DE, et al. The clinical information value of the glycosylated hemoglobin assay.New England Journal of Medicine.1983;29:466-9.

Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes. 1996;45(5): 695-8.

Chessler SD, Fujimoto WY, Shofer JB, Boyko EJ, Weigle DS. Increased plasma leptin levels are associated with fat accumulation in Japanese Americans. Diabetes. 1998;47(2):239-43.

Fernhurst Dr. Enzyme-linked immunosorbentb assay kit for visceral adipose tissue derived serine protease inhibitor (Vaspin). Instruction manual. 12th ed. Cloud-Clone Corp. 2017;1-5.

Brennan A M, et al. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: A prospective cohort study. Diabetologia. 2007;50:1178–85.

Youn BS, Klo¨ting N, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes. 2008;57:372–7.

Krasnodebski P, et al. Leptin in coronary artery disease and period of convalescence in patients with type 2 diabetes mellitus. Kardiol Pol. 2010;68: 648–53.

Paul RF, Hassan M, et al. Effect of body mass index on serum leptin levels. J Ayub Med Coll Abbottabad. 2011;23:40-3.

Kazmi A, et al. Association of leptin with type diabetes in non-obese subjects. J Ayub Med Coll Abbottabad. 2012;24:186-9.

Das P, Bhattacharjee D, et al. Association of obesity and leptin with insulin resistance in type diabetes mellitus in Indian population. Indian J Physiol Pharmacol. 2013;57:45-50.

Feng R-N, Wang C, et al. Vaspin in newly and previously diagnosed Chinese type 2 diabetic females: a case-control study. Asian Biomedicine. 2011;5(4):525–9.

Najam SS, Awan FR, et al. Leptin correlation with obesity, diabetes and gender in a population from Faisalabad, Pakistan. Arch Med. 2016;8:5-9.

Ahmed AE, et al. Correlation between plasma leptin hormone in diabetic patients and the extent of coronary artery disease. Menoufia Medical Journal. 2018;31:60.

Youn BS, Klo¨ting N, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes. 2008;57:372–7.

Sun G, Li L, Yang M, Liu H, Nowicki M, Zong H, Yang G. Ann. Med. 2009;41: 311.

Li Z, Ma C, Li L, et al. Vaspin serum concentration in patients with type 2 diabetes and carotid plaque. The Journal of International Medical Research. 2012; 40(5):1670–6.

Atya HB, Hassan ZA, et al. Vaspin concentration in obesity, impaired glucose tolerance and type 2 diabetes in Egypt. Advanced Research in Biological Sciences. 2013;1(1):6–13.

Jian W, Peng W, Xiao S, Li H, Jin J, Qin L, et al. Role of serum vaspin in progression of type 2 diabetes: A 2-Year Cohort Study. PLOS ONE. 2014;9(4):e94763.

Dai R, Dong Z, et al. Obese type 2 diabetes mellitus patients have higher serum vaspin concentrations. Journal of Diabetes. 2016;8(3):445–7.

Al-Dujaili AN, Hassan AB, et al. Assesment of vaspin and risk factors in relation with diabetes mellitus type2. Rasayan J. Chem. 2016;9(4):566-72.

Ye Y, Hou XH, et al. Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes. Chinese Medical Journal. 2009;122(21): 2530–3.

Li K, Li L, Yang M, et al. Short-termcontinuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity. European Journal of Endocrinology. 2011;164(6):905–10.

Seeger J, Ziegelmeier M, Bachmann A, Lössner U, et al. Serum levels of the adipokine Vaspin in relation to metabolic and renal parameters. J. Clin. Endocrinol. Metab. 2008;93:247-51.

Horn R, Geldszus R, Pötter E, von zur Mühlen A, et al. Radioimmunoassay for the detection of leptin in human serum. Exp. Clin. Endocrinol. Diabetes. 1996; 104:454-58.

Ma Z, Gingerich RL, Santiago JV, Klein S, et al. Radioimmunoassay of leptin in human plasma. Clin. Chem. 1996;42:942-6.